U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07885605) titled 'Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease' on Oct. 01.
Brief Summary: The primary objective of study is to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ETHY-001 in healthy volunteers and participants with Thyroid Eye Disease after single subcutaneous doses.
Study Start Date: July 06
Study Type: INTERVENTIONAL
Condition:
Thyroid Eye Disease (TED)
Graves' Disease
Eye Diseases, Hereditary
Eye Diseases
Exophthalmos
Orbital Diseases
Goiter
Thyroid Diseases
Endocrine System Diseases
Hyperthyroidism
Autoimmune Diseases
Immune System Diseases
Graves O...